Regulus Therapeutics Stock Price Prediction
| RGLS Stock | USD 1.61 0.03 1.83% |
Oversold Vs Overbought
44
Oversold | Overbought |
EPS Estimate Next Quarter (0.17) | EPS Estimate Current Year (0.88) | EPS Estimate Next Year (1.36) | Wall Street Target Price 10.3333 | Quarterly Revenue Growth 276.778 |
Using Regulus Therapeutics hype-based prediction, you can estimate the value of Regulus Therapeutics from the perspective of Regulus Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Regulus Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Regulus because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Regulus Therapeutics after-hype prediction price | USD 1.61 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Regulus |
Regulus Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Regulus Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Regulus Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Regulus Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Regulus Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Regulus Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Regulus Therapeutics' historical news coverage. Regulus Therapeutics' after-hype downside and upside margins for the prediction period are 0.08 and 5.72, respectively. We have considered Regulus Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Regulus Therapeutics is very risky at this time. Analysis and calculation of next after-hype price of Regulus Therapeutics is based on 3 months time horizon.
Regulus Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Regulus Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Regulus Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Regulus Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.12 | 4.11 | 0.00 | 0.01 | 8 Events / Month | 4 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.61 | 1.61 | 0.00 |
|
Regulus Therapeutics Hype Timeline
Regulus Therapeutics is at this time traded for 1.61. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.01. Regulus is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is expected to be very small, whereas the daily expected return is at this time at 0.12%. %. The volatility of related hype on Regulus Therapeutics is about 5871.43%, with the expected price after the next announcement by competition of 1.62. About 88.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.21. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Regulus Therapeutics recorded a loss per share of 1.02. The entity last dividend was issued on the 4th of October 2018. The firm had 1:10 split on the 29th of June 2022. Given the investment horizon of 90 days the next expected press release will be in about 8 days. Check out Regulus Therapeutics Basic Forecasting Models to cross-verify your projections.Regulus Therapeutics Related Hype Analysis
Having access to credible news sources related to Regulus Therapeutics' direct competition is more important than ever and may enhance your ability to predict Regulus Therapeutics' future price movements. Getting to know how Regulus Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Regulus Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| INFI | Infinity Pharmaceuticals | 0.01 | 1 per month | 8.66 | (0.0006) | 13.33 | (12.50) | 50.00 | |
| TENX | Tenax Therapeutics | (0.01) | 4 per month | 2.40 | 0.12 | 5.49 | (4.48) | 18.78 | |
| VSTM | Verastem | (0.50) | 10 per month | 4.51 | 0.20 | 12.84 | (5.69) | 31.27 | |
| PULM | Pulmatrix | 0.82 | 4 per month | 3.56 | 0.18 | 16.69 | (4.79) | 92.85 | |
| CLRB | Cellectar Biosciences | 0.03 | 6 per month | 0.00 | (0.25) | 2.94 | (4.23) | 15.85 |
Regulus Therapeutics Additional Predictive Modules
Most predictive techniques to examine Regulus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Regulus using various technical indicators. When you analyze Regulus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Regulus Therapeutics Predictive Indicators
The successful prediction of Regulus Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Regulus Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Regulus Therapeutics based on analysis of Regulus Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Regulus Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Regulus Therapeutics's related companies. | 2023 | 2024 (projected) | Graham Number | 6.31 | 6.0 | Receivables Turnover | 22.88 | 42.26 |
Story Coverage note for Regulus Therapeutics
The number of cover stories for Regulus Therapeutics depends on current market conditions and Regulus Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Regulus Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Regulus Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Regulus Therapeutics Short Properties
Regulus Therapeutics' future price predictability will typically decrease when Regulus Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Regulus Therapeutics often depends not only on the future outlook of the potential Regulus Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Regulus Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 19 M | |
| Cash And Short Term Investments | 23.8 M |
Additional Tools for Regulus Stock Analysis
When running Regulus Therapeutics' price analysis, check to measure Regulus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regulus Therapeutics is operating at the current time. Most of Regulus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Regulus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regulus Therapeutics' price. Additionally, you may evaluate how the addition of Regulus Therapeutics to your portfolios can decrease your overall portfolio volatility.